Key Points GAAP loss per share of $0.55 in Q2 2025 beat analyst estimates by $1.13. GAAP revenue of $5.5 million in Q2 2025 missed expectations by 26%. Advanced key clinical programs, with first U.S.

This week, a lusty “Outlander” prequel arrives to steam up your TV and give romance lovers a boost. We review that, along ...

Having won silverware in each of his two full seasons with the Reds, Cody Gakpo - who scored twice in Liverpool's final ...

A HMEDABAD, India, Aug. 6, 2025 /PRNewswire/ -- Intas Pharmaceuticals in collaboration with its global subsidiaries operating under the Accord brand, has solidified its position as one of the world's ...

On Sept. 17, 2024, thousands of pagers distributed to the Hezbollah group exploded across Lebanon, remotely detonated by ...